Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

3SBio Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

07 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - 3SBio Inc (1530-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 May 2016 Thomson Reuters Stock Report 11 $25.00

Thomson Reuters Stock Report - 3SBio Inc (1530-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

11 May 2016 Thomson Reuters Stock Report 11 $25.00

Trading Report for (SSRX). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for SSRX. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

11 May 2016 Stock Traders Daily 5 $20.00

3SBio Inc. (1530) - Financial and Strategic SWOT Analysis Review

3SBio Inc. (1530) - Financial and Strategic SWOT Analysis Review Summary 3SBio Inc. (3SBio) is one of the leading biotechnolo...

04 May 2016 GlobalData 66 $300.00

Wright Investors Service Comprehensive Report for 3sbio Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

01 May 2016 Wright Reports 55 $75.00

3SBio Inc. (1530) - Strategic SWOT Analysis Review

3SBio Inc. (1530) - Strategic SWOT Analysis Review Summary 3SBio Inc. (3SBio) is one of the leading biotechnology companies i...

02 Mar 2016 GlobalData 56 $300.00

Core Pacific - Yamaichi [3SBio (1530 HK) : NOT RATED - Biopharm leader looking for acquisition to drive growth](2016/02/19)

What’s New We had an investor relation meeting with 3S Bio, a major biopharm company in China. Catalyst Innovative drug ...

19 Feb 2016 Core Pacific - Yamaichi International (H.K.) Limited 3 $35.00

3SBio Inc. (1530) - Strategic SWOT Analysis Review

3SBio Inc. (1530) - Strategic SWOT Analysis Review Summary 3SBio Inc. (3SBio) is one of the leading biotechnology companies i...

07 Dec 2015 GlobalData 55 $300.00

3SBio Inc. (1530) - Strategic SWOT Analysis Review

3SBio Inc. (1530) - Strategic SWOT Analysis Review Summary 3SBio Inc. (3SBio) is one of the leading biotechnology compa...

18 Sep 2015 GlobalData 27 $125.00